Heron Therapeutics, Inc.
HRTX
$2.48
$0.093.77%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 59.28M | 70.89M | 67.35M | 71.52M | 80.41M |
| Total Receivables | 78.88M | 67.04M | 73.71M | 65.32M | 60.14M |
| Inventory | 53.16M | 45.95M | 42.86M | 42.47M | 42.11M |
| Prepaid Expenses | 17.69M | 11.31M | 7.25M | 6.58M | 6.12M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 209.01M | 195.19M | 191.17M | 185.90M | 188.77M |
|
|
|||||
| Total Current Assets | 209.01M | 195.19M | 191.17M | 185.90M | 188.77M |
| Net Property, Plant & Equipment | 17.65M | 18.88M | 20.04M | 24.10M | 25.60M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.48M | 6.71M | 6.93M | 7.88M | 8.13M |
| Total Assets | 233.15M | 220.78M | 218.14M | 217.89M | 222.51M |
|
|
|||||
| Total Accounts Payable | 11.71M | 10.19M | 10.23M | 837.00K | 3.24M |
| Total Accrued Expenses | 76.71M | 37.22M | 29.88M | 32.73M | 73.37M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.04M | 3.25M | 3.19M | 3.14M | 3.08M |
| Total Finance Division Other Current Liabilities | -- | 34.88M | 37.02M | 38.67M | -- |
| Total Other Current Liabilities | -- | 34.88M | 37.02M | 38.67M | -- |
| Total Current Liabilities | 91.46M | 85.54M | 80.32M | 75.38M | 79.69M |
|
|
|||||
| Total Current Liabilities | 91.46M | 85.54M | 80.32M | 75.38M | 79.69M |
| Long-Term Debt | 174.73M | 174.48M | 174.23M | 173.99M | 173.75M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 522.00K | 1.29M | 2.05M | 2.80M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 615.00K | 241.00K | 241.00K | 241.00K | 241.00K |
| Total Liabilities | 266.80M | 260.78M | 256.08M | 251.65M | 256.48M |
|
|
|||||
| Common Stock & APIC | 1.89B | 1.88B | 1.88B | 1.88B | 1.87B |
| Retained Earnings | -1.92B | -1.92B | -1.92B | -1.91B | -1.91B |
| Treasury Stock & Other | 13.00K | 40.00K | -8.00K | -6.00K | 13.00K |
| Total Common Equity | -33.65M | -40.01M | -37.94M | -33.77M | -33.97M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -33.65M | -40.01M | -37.94M | -33.77M | -33.97M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -33.65M | -40.01M | -37.94M | -33.77M | -33.97M |
|
|
|||||
